| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 21.05.
| Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012 | | 50 | PR Newswire |
| JERUSALEM, Israel, May 21, 2012 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, announced today that it was chosen to present at the 11th National...
Mehr lesen zu:
Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012 | |
| 17.05.
| Oramed wins Israeli patent for core delivery technology | | 5 | Pharma Bus Review |
| 16.05.
| Oramed Pharmaceuticals Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins | | 28 | Business Wire |
| Marking a major milestone for the company, Oramed Pharmaceuticals Inc.
(OTCBB:ORMP) (www.oramed.com),
a developer of oral drug delivery systems, announced today that it...
Mehr lesen zu:
Oramed Pharmaceuticals Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins | |
| 10.05.
| Oramed wins Israeli government grant to advance oral insulin studies | | 2 | Pharma Bus Review |
| 08.05.
| Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel | | 16 | Business Wire |
| Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (http://www.oramed.com),
a developer of oral delivery systems, announced today that its wholly
owned Israeli subsidiary, Oramed...
Mehr lesen zu:
Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel | |
| 04.04.
| ORAMED PHARMACEUTICALS INC. - 10-Q, Quarterly Report | | 12 | SEC Filings |
| 20.03.
| Oramed Pharmaceuticals Chosen to Present at the XVI International Symposium on Atherosclerosis (ISA2012), (March 25-29, 2012; Sydney, Australia) | | 48 | Business Wire |
| Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (www.oramed.com),
a developer of oral drug delivery systems, announced today that its work
entitled "Decreased CRP levels in...
Mehr lesen zu:
Oramed Pharmaceuticals Chosen to Present at the XVI International Symposium on Atherosclerosis (ISA2012), (March 25-29, 2012; Sydney, Australia) | |
| 07.02.
| Oramed Pharmaceuticals Announces Educational Lecture at the National University Hospital in Singapore | | 22 | PR Newswire |
| JERUSALEM, February 7, 2012 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that Dr Miriam Kidron, Oramed's...
Mehr lesen zu:
Oramed Pharmaceuticals Announces Educational Lecture at the National University Hospital in Singapore | |
| 26.01.
| Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins | | 11 | PR Newswire |
| JERUSALEM, January 24, 2012 /PRNewswire/ --
Marking a major milestone for the Company, Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems...
Mehr lesen zu:
Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins | |
| 12.01.
| ORAMED PHARMACEUTICALS INC. - 10-Q, Quarterly Report | | 7 | SEC Filings |
| 10.01.
| Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes | | 27 | PR Newswire |
| JERUSALEM, January 10, 2012 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed a provisional...
Mehr lesen zu:
Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes | |
| 12.12.
| Corporate Profile's CPReports.com Publishes Goldman Small Cap Research's Article on Oramed Pharmaceuticals | | 43 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 12/12/11 -- Corporate Profile's financial website www.CPreports.com announces article on Oramed Pharmaceuticals, Inc. (OTCBB: ORMP) (OTCQB: ORMP).
To view report:...
Mehr lesen zu:
Corporate Profile's CPReports.com Publishes Goldman Small Cap Research's Article on Oramed Pharmaceuticals | |
